Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02481674
Brief Title: A Study in Subjects With Late Prodromal and Early Manifest Huntington's Disease (HD) to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Pepinemab (VX15/2503) (SIGNAL)

First Submitted : June 19, 2015
First Submitted that Met QC Criteria : June 23, 2015
First Posted : June 25, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : September 16, 2020
Last Update Posted : September 17, 2020